MedPath

Comparison of efficacy of metformin plus dapagliflozin versus metformin plus insulin sensitizer in patients having diabetes mellitus type-2 in Pakistan.

Not Applicable
Conditions
Diabetes Mellitus Type 2
Metabolic and Endocrine - Diabetes
Registration Number
ACTRN12622000243718
Lead Sponsor
Dr. Malik Hassan Mehmood
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
84
Inclusion Criteria

1) Subject having Type-2 diabetes mellitus
2) Both Male & Female
3)Patients having glycated hemoglobin ranging between 6.5 to 12.5%
4)Age from 30 to 80 year
5)BMI greater than 23 kg/m^2
6)Patients who can understand and give consent for study

Exclusion Criteria

1)Patients not using any oral anti diabetic combination from previous 4 weeks.
2)Subject having type 1 diabetes mellitus.
3)Person with history of blood pressure greater than 180 mm of Hg
4)Pregnancy
5)Patients with renal insufficiency
6) Lactating females
7) Dementia

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath